Cabozantinib
compare suppliers & send inquiries for free

Filters

Reset

Selected filters:

Type
Region
Qualifications
Country of origin

HIGHLIGHTED

Located in:

China

Produced in:

China

Established in: 2013

MOQ: 1 g

Employees: 25+

ISO9001 certified

Drug R&D center (in Hangzhou)

From lab scale (mg/g) to commercial scale (kgs/tons)

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

Send inquiry

Replies quickly

Located in:

India

Producer

MSN Labs.

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • CoA

Send inquiry

Not active

How does it work?

1
Register for free
icon

You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry

2
Start sourcing
icon

Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only

3
Send inquiries
icon

Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week

4
Get quotation
icon

Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news

5
Arrange agreement
icon

Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module

Looking for Cabozantinib 849217-68-1?

Description:
Here you will find a list of producers, manufacturers and traders of Cabozantinib. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Cabozantinib 
Synonyms:
 
Cas Number:
849217-68-1 
DrugBank number:
DB08875 
Unique Ingredient Identifier:
1C39JW444G

About Cabozantinib

What can you use it for? Cabozantinib was first approved in 2012 and is a non-specific tyrosine kinase inhibitor. It was initially approved in the US under the brand name Cometriq, which is indicated for the treatment of metastatic medullary thyroid cancer. In 2016, a capsule formulation (Cabometyx) was approved for the treatment of advanced renal cell carcinoma, and this same formulation gained additional approval in both the US and Canada in 2019 for the treatment of hepatocellular carcinoma in previously treated patients

Not sure if this is the exact product you're looking for? Contact the supplier by using the send inquiry button.

Cabozantinib manufacturers | traders | suppliers

We have 2 companies offering Cabozantinib from 2 different countries.

Get in contact with the supplier of your choice:

  • SENOVA Technology Co., Ltd. from China
  • MSN Labs. from India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.